GlassScriptPhysician profile
Paul K Anderson
NPI 1578676664
$3,104.05
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $762 · 2021: $1,789 · 2022: $17.31 · 2023: $18.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,491.56 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $312.76 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $191.64 | 2019-2021 | |
| Gilead Sciences, INC. | $174.77 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $116.22 | 2021 | |
| Nestle Healthcare Nutrition INC. | $110.39 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $85.33 | 2021 | |
| Redhill Biopharma INC. | $67.96 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $67.10 | 2019-2021 | |
| Pfizer INC. | $60.98 | 2019 | |
| Qol Medical, LLC | $51.73 | 2019-2021 | |
| Braintree Laboratories, INC. | $41.04 | 2019-2021 | |
| Daiichi Sankyo INC. | $32.67 | 2020-2021 | |
| Celgene Corporation | $31.42 | 2021-2022 | |
| Organon LLC | $31.06 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $30.88 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.42 | 2020-2021 | |
| Allergan, INC. | $24.16 | 2019 | |
| Vivus LLC | $23.48 | 2021 | |
| Shire North American Group INC | $21.95 | 2019 | |
| Amgen INC. | $20.03 | 2020 | |
| Boston Scientific Corporation | $18.49 | 2023 | Wavewriter Alpha Prime 16 |
| Biofire Diagnostics, LLC | $18.01 | 2020 | |
| Evoke Pharma, INC. | $16.04 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $12.27 | 2021 | |
| Dynavax Technologies Corporation | $12.21 | 2019 | |
| Janssen Biotech, INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.